Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Iranian Journal of Cancer Prevention|March 31, 2015
Incidence of Seminoma Cancer in Staffs that Worked in Electromagnetic Waves Station; Three Cases ReportMohammad Houshyari, Anya Jafari, Ahmad Mostaar
Critical Reviews in Oncology/Hematology|May 28, 2020
Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatmentsAnya Jafari, Sahar Dadkhahfar, Sahra Perseh
Journal of Medical Case Reports|April 29, 2021
Simultaneous development of COVID-19 pneumonia and pulmonary metastasis in a known case of chondrosarcoma: a case reportAfshin Rakhsha, Zahra Mahboubi-Fooladi, Anya Jafari
Urology Journal|September 13, 2018
Primary Prostate Lymphoma Managed with Combined Modality Treatment: A Case ReportAnya Jafari, Bahram Mofid, Ali Tabibi, et al.
Journal of Cancer Research and Therapeutics|February 22, 2024
Top cited publications for treatment of keloid with radiotherapy: A Bibliometric analysisZahra Siavashpour, Mohammad Houshyari, Sahar Dadkhahfar, et al.
BMC Medical Imaging|January 3, 2025
Diffusion-weighted MRI-Derived ADC and tumor volume as predictive imaging markers for neoadjuvant chemotherapy response in muscle-invasive bladder cancerAbolfazl Razzaghdoust, Anya Jafari, Arash Mahdavi, et al.
Urology Journal|March 5, 2022
Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective AnalysisBahram Mofid, Abolfazl Razzaghdoust, Mahdi Ghajari, et al.
Investigative and Clinical Urology|May 4, 2021
Association of immunohistochemical markers of tumor subtype with response to neoadjuvant chemotherapy and survival in patients with muscle-invasive bladder cancerAbolfazl Razzaghdoust, Mahdi Ghajari, Abbas Basiri, et al.
BMC Urology|May 25, 2026
Bladder-sparing chemoradiotherapy following neoadjuvant chemotherapy for muscle-invasive bladder cancer: a retrospective cohort studyBahram Mofid, Anya Jafari, Nasser Simforoosh, et al.
Expert Opinion on Drug Safety|July 30, 2024
Safety evaluation of the trastuzumab biosimilar in Iranian women with HER2-positive breast cancer undergoing adjuvant chemotherapy: a post-marketing surveillanceFatemeh Zahedi, Anya Jafari, Behnam Nasiri Motlagh, et al.
Pageof 1